Changes in serum phosphate during beta-blockade in healthy men are not due to changes in the renal handling of phosphate
- PMID: 2649632
- DOI: 10.1111/j.1365-2796.1989.tb00063.x
Changes in serum phosphate during beta-blockade in healthy men are not due to changes in the renal handling of phosphate
Abstract
Serum parathyroid hormone (PTH), phosphate, ionized calcium, magnesium, alkaline phosphatase and creatinine and the urinary excretion of phosphate and creatinine were studied after 1 and 3 weeks beta-blockade in 32 young healthy men given either atenolol at 50 mg, metoprolol at 100 mg, propranolol at 80 mg or placebo twice a day. After 1 week treatment serum phosphate (mean (range] increased in the propranolol-treated subjects (1.17 (0.99-1.30) to 1.32 (1.08-1.71) mmol l-1 (P = 0.03), minor changes were found in the atenolol and the metoprolol-treated subjects but not in the placebo group. Serum phosphate was unchanged compared to pretreatment values after 3 weeks. Renal clearance and urinary excretion of phosphate and creatinine was unchanged after both 1 and 3-weeks treatment. Serum PTH, ionized calcium, magnesium and alkaline phosphatase were unchanged in all groups, whereas serum urate and creatinine increased in the metoprolol-treated subjects after both 1 and 3 weeks.
Similar articles
-
Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.Eur J Clin Pharmacol. 1989;36(1):67-70. doi: 10.1007/BF00561026. Eur J Clin Pharmacol. 1989. PMID: 2917591 Clinical Trial.
-
Serum magnesium, calcium, phosphate and PTH following long-term beta-blockade in ischaemic heart disease.Eur J Clin Pharmacol. 1988;34(3):299-301. doi: 10.1007/BF00540959. Eur J Clin Pharmacol. 1988. PMID: 2899511 Clinical Trial.
-
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.Eur J Clin Pharmacol. 1982;21(5):379-84. doi: 10.1007/BF00542322. Eur J Clin Pharmacol. 1982. PMID: 7075643
-
Interaction of cimetidine with metoprolol, propranolol, or atenolol.Lancet. 1981 Sep 5;2(8245):531-2. doi: 10.1016/s0140-6736(81)90921-1. Lancet. 1981. PMID: 6115283 No abstract available.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources